Vyvanse, a medication containing lisdexamfetamine dimesylate, is commonly prescribed to treat ADHD and moderate to severe binge eating disorder (BED). Its innovative prodrug formulation means it only becomes active after the body metabolizes it, which helps reduce the risk of abuse.